ADAMTS13 and endometriosis: The findings demonstrated that the genetically predicted plasma ADAMTS13 level is causally associated with a decreased risk of endometriosis (IVW: OR = 0.37, 95%CI: 0.22–0.61, P = 1.25e − 4; WM: OR = 0.41, 95%CI: 0.23–0.72, P = 2.05e − 3) (Fig. 2A, Additional file 1: Table S2, Additional file 2: Fig. S1).